jueves, 3 de septiembre de 2026
Blood-based CRC screening: closer, but not there yet The Lancet Gastroenterology & Hepatology ++... ++
Blood-based CRC screening: closer, but not there yet
The Lancet Gastroenterology & Hepatology
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00244-X/fulltext?dgcid=raven_jbs_etoc_email
Oct 2026
Volume 11Number 10p863-942, e11
https://www.thelancet.com/journals/langas/issue/vol11no10/PIIS2468-1253(26)X2008-8
A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study
Alessandro Mannucci, MDa,b ∙ Caiming Xu, MDa ∙ Prof Francesc Balaguer, MDd ∙ Prof Yoshinaga Okugawa, MDe ∙ Prof Yuji Toiyama, MDe ∙ Prof Miguel Pera, MDf ∙ et al.
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00180-9/abstract?dgcid=raven_jbs_etoc_feature_langas
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
Prof Mazen Noureddin, MDa,b,c,d Send email to noureddinmd@pinnacleresearch.com ∙ Prof Winston Dunn, MDc,e ∙ Rashmee Patil, MDc ∙ Dimple Desai, MDc ∙ Rohit Puskoor, MDc ∙ Jaehee Shin, MSf ∙ et al.
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00130-5/abstract?dgcid=raven_jbs_etoc_feature_langas
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario